← 返回

实时成像揭示的 CAR-T 细胞行为与功能

英文原题:CAR T-cell behavior and function revealed by real-time imaging.

查看英文原题

CAR T-cell behavior and function revealed by real-time imaging.

PubMed 2023/01/23(内容时间) Semin Immunopathol Q1 · IF 11.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

表达嵌合抗原受体(CAR)的T细胞过继转移已在晚期B细胞恶性肿瘤治疗中显示显著临床疗效。然而,CAR-T 细胞领域目前仍面临若干重大挑战。尤其是靶向实体瘤时,CAR-T 细胞策略尚未取得理想临床反应。

因此,了解限制T细胞免疫疗法疗效的决定因素至关重要。CAR-T 细胞通常通过流式细胞术和全转录组分析进行表征;这些方法对于确定影响T细胞增殖和扩增能力的内在因素非常有价值,但未考虑T细胞反应的空间和动力学特征。特别是,为控制肿瘤生长,CAR-T 细胞必须进入肿瘤,在复杂肿瘤环境中迁移,并与靶细胞形成有效接触。先进成像技术与创新性临床前模型相结合,为揭示CAR-T 细胞动态提供了有前景的工具。本综述讨论近期利用实时成像显微技术获得的工程化T细胞生物学研究结果。基于成像的研究提出了重要认识,例如CAR-T 细胞具有多重杀伤潜力。

最后,本文介绍如何将成像技术与其他工具结合,以解决工程化T细胞领域尚未解答的问题。

展开英文摘要原文

Adoptive transfer of T-cells expressing chimeric antigen receptors (CAR) has shown remarkable clinical efficacy against advanced B-cell malignancies. Nonetheless, the field of CAR T-cells is currently facing several major challenges. In particular, the CAR T-cell strategy has not yet produced favorable clinical responses when targeting solid tumors.

In this context, it is of paramount importance to understand the determinants that limit the efficacy of T-cell-based immunotherapy. Characterization of CAR T-cells is usually based on flow cytometry and whole-transcriptome profiling. These approaches have been very valuable to determine intrinsic elements that condition T-cell ability to proliferate and expand.

However, they do not take into account spatial and kinetic aspects of T-cell responses. In particular, in order to control tumor growth, CAR T-cells need to enter into the tumor, migrate within a complex tumor environment, and form productive conjugates with their targets.

Advanced imaging techniques combined with innovative preclinical models represent promising tools to uncover the dynamics of CAR T-cells. In this review, we will discuss recent results on the biology of engineered T-cells that have been obtained with real-time imaging microscopy. Important notions have emerged from these imaging-based studies, such as the multi-killing potential of CAR T-cells.

Finally, we will highlight how imaging techniques combined with other tools can solve remaining unresolved questions in the field of engineered T-cells.

论文信息

作者
Espie D、Donnadieu E
第一作者单位
Université Paris Cité, CNRS, INSERM, Equipe Labellisée Ligue Contre le Cancer, Institut Cochin, INSERM U1016, 22 rue Méchain, F-75014, Paris, France.France
通讯作者单位
Université Paris Cité, CNRS, INSERM, Equipe Labellisée Ligue Contre le Cancer, Institut Cochin, INSERM U1016, 22 rue Méchain, F-75014, Paris, France. emmanuel.donnadieu@inserm.fr.France
文献类型
综述 · 非美国政府资助研究
期刊
Seminars in immunopathology2023 Mar
原文标识
PubMed 36688965 · DOI 10.1007/s00281-023-00983-7